Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3853 to 3858 of 3858 entries
Sorted by: Best Match Show Resources per page
Identifying Issues in Fertility Preservation for Childhood and Adolescent Patients with Cancer at Pediatric Oncology Hospitals in Japan.

Journal of adolescent and young adult oncology

Maezawa T, Suzuki N, Takeuchi H, Kiyotani C, Amano K, Keino D, Okimura H, Miyachi M, Goto M, Takae S, Horie A, Takita J, Sago H, Hirayama M, Ikeda T, Matsumoto K.
PMID: 34297622
J Adolesc Young Adult Oncol. 2021 Jul 22; doi: 10.1089/jayao.2021.0088. Epub 2021 Jul 22.

No abstract available.

Cite
Maezawa T, Suzuki N, Takeuchi H, et al. Identifying Issues in Fertility Preservation for Childhood and Adolescent Patients with Cancer at Pediatric Oncology Hospitals in Japan. J Adolesc Young Adult Oncol. 2021;doi: 10.1089/jayao.2021.0088.
Maezawa, T., Suzuki, N., Takeuchi, H., Kiyotani, C., Amano, K., Keino, D., Okimura, H., Miyachi, M., Goto, M., Takae, S., Horie, A., Takita, J., Sago, H., Hirayama, M., Ikeda, T., & Matsumoto, K. (2021). Identifying Issues in Fertility Preservation for Childhood and Adolescent Patients with Cancer at Pediatric Oncology Hospitals in Japan. Journal of adolescent and young adult oncology, . https://doi.org/10.1089/jayao.2021.0088
Maezawa, Tadashi, et al. "Identifying Issues in Fertility Preservation for Childhood and Adolescent Patients with Cancer at Pediatric Oncology Hospitals in Japan." Journal of adolescent and young adult oncology vol. (2021). doi: https://doi.org/10.1089/jayao.2021.0088
Maezawa T, Suzuki N, Takeuchi H, Kiyotani C, Amano K, Keino D, Okimura H, Miyachi M, Goto M, Takae S, Horie A, Takita J, Sago H, Hirayama M, Ikeda T, Matsumoto K. Identifying Issues in Fertility Preservation for Childhood and Adolescent Patients with Cancer at Pediatric Oncology Hospitals in Japan. J Adolesc Young Adult Oncol. 2021 Jul 22; doi: 10.1089/jayao.2021.0088. Epub 2021 Jul 22. PMID: 34297622.
Copy Download .nbib Format: NLM
Identification of ksg1 mutation showing long-lived phenotype in fission yeast.

Genes to cells : devoted to molecular & cellular mechanisms

Matsui K, Okamoto K, Hasegawa T, Ohtsuka H, Shimasaki T, Ihara K, Goto Y, Aoki K, Aiba H.
PMID: 34534388
Genes Cells. 2021 Dec;26(12):967-978. doi: 10.1111/gtc.12897. Epub 2021 Sep 26.

Fission yeast is a good model organism for the study of lifespan. To elucidate the mechanism, we screened for long-lived mutants. We found a nonsense mutation in the ksg1

Cite
Matsui K, Okamoto K, Hasegawa T, et al. Identification of ksg1 mutation showing long-lived phenotype in fission yeast. Genes Cells. 2021;26(12):967-978doi: 10.1111/gtc.12897.
Matsui, K., Okamoto, K., Hasegawa, T., Ohtsuka, H., Shimasaki, T., Ihara, K., Goto, Y., Aoki, K., & Aiba, H. (2021). Identification of ksg1 mutation showing long-lived phenotype in fission yeast. Genes to cells : devoted to molecular & cellular mechanisms, 26(12), 967-978. https://doi.org/10.1111/gtc.12897
Matsui, Kotaro, et al. "Identification of ksg1 mutation showing long-lived phenotype in fission yeast." Genes to cells : devoted to molecular & cellular mechanisms vol. 26,12 (2021): 967-978. doi: https://doi.org/10.1111/gtc.12897
Matsui K, Okamoto K, Hasegawa T, Ohtsuka H, Shimasaki T, Ihara K, Goto Y, Aoki K, Aiba H. Identification of ksg1 mutation showing long-lived phenotype in fission yeast. Genes Cells. 2021 Dec;26(12):967-978. doi: 10.1111/gtc.12897. Epub 2021 Sep 26. PMID: 34534388.
Copy Download .nbib Format: NLM
A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation.

CEN case reports

Hayashi S, Ohashi N, Goto D, Isomura N, Isobe S, Fujikura T, Fujigaki Y, Shimizu A, Ito H, Yasuda H.
PMID: 33721266
CEN Case Rep. 2021 Nov;10(4):476-482. doi: 10.1007/s13730-021-00592-z. Epub 2021 Mar 15.

Preeclampsia and superimposed preeclampsia usually develop after 20 weeks of gestation. We report a case of a 35-year-old Japanese woman who developed hypertensive disorders of pregnancy (HDP) before 20 weeks of gestation. She presented with hypertension and proteinuria at...

Cite
Hayashi S, Ohashi N, Goto D, et al. A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation. CEN Case Rep. 2021;10(4):476-482doi: 10.1007/s13730-021-00592-z.
Hayashi, S., Ohashi, N., Goto, D., Isomura, N., Isobe, S., Fujikura, T., Fujigaki, Y., Shimizu, A., Ito, H., & Yasuda, H. (2021). A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation. CEN case reports, 10(4), 476-482. https://doi.org/10.1007/s13730-021-00592-z
Hayashi, Saki, et al. "A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation." CEN case reports vol. 10,4 (2021): 476-482. doi: https://doi.org/10.1007/s13730-021-00592-z
Hayashi S, Ohashi N, Goto D, Isomura N, Isobe S, Fujikura T, Fujigaki Y, Shimizu A, Ito H, Yasuda H. A case of hypertensive disorders of pregnancy that developed at 9 weeks of gestation. CEN Case Rep. 2021 Nov;10(4):476-482. doi: 10.1007/s13730-021-00592-z. Epub 2021 Mar 15. PMID: 33721266; PMCID: PMC8494829.
Copy Download .nbib Format: NLM
COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.

Modern rheumatology case reports

Kawasaki T, Ooka S, Mizushima M, Nakamura Y, Ikeda H, Sakurada T, Suzuki S, Yamazaki K, Goto Y, Sakurai K, Yukitaka Y, Kiyokawa T, Tonooka K, Kunishima H, Kawahata K.
PMID: 34592766
Mod Rheumatol Case Rep. 2022 Jan 07;6(1):101-105. doi: 10.1093/mrcr/rxab032.

The coronavirus disease (COVID-19) is known to cause hyperferritinemia and haemophagocytic lymphohistiocytosis. Including this laboratory parameter, symptoms similar to COVID-19 have been observed in adult-onset Still's disease (AOSD), catastrophic antiphospholipid syndrome, macrophage activation syndrome, and septic shock, which has...

Cite
Kawasaki T, Ooka S, Mizushima M, et al. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes. Mod Rheumatol Case Rep. 2022;6(1):101-105doi: 10.1093/mrcr/rxab032.
Kawasaki, T., Ooka, S., Mizushima, M., Nakamura, Y., Ikeda, H., Sakurada, T., Suzuki, S., Yamazaki, K., Goto, Y., Sakurai, K., Yukitaka, Y., Kiyokawa, T., Tonooka, K., Kunishima, H., & Kawahata, K. (2022). COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes. Modern rheumatology case reports, 6(1), 101-105. https://doi.org/10.1093/mrcr/rxab032
Kawasaki, Tatsuya, et al. "COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes." Modern rheumatology case reports vol. 6,1 (2022): 101-105. doi: https://doi.org/10.1093/mrcr/rxab032
Kawasaki T, Ooka S, Mizushima M, Nakamura Y, Ikeda H, Sakurada T, Suzuki S, Yamazaki K, Goto Y, Sakurai K, Yukitaka Y, Kiyokawa T, Tonooka K, Kunishima H, Kawahata K. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes. Mod Rheumatol Case Rep. 2022 Jan 07;6(1):101-105. doi: 10.1093/mrcr/rxab032. PMID: 34592766; PMCID: PMC8500156.
Copy Download .nbib Format: NLM
Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis.

Yonago acta medica

Goto H, Sugita K, Yamamoto O.
PMID: 34429706
Yonago Acta Med. 2021 Aug 02;64(3):315-317. doi: 10.33160/yam.2021.08.008. eCollection 2021 Aug.

Recent studies have shown that complete lymph node dissection (CLND) performed immediately did not improve the overall survival in patients with sentinel lymph node (LN)-positive melanoma. According to these results, nodal observation with ultrasonography becomes standard. However, it still...

Cite
Goto H, Sugita K, Yamamoto O. Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis. Yonago Acta Med. 2021;64(3):315-317doi: 10.33160/yam.2021.08.008.
Goto, H., Sugita, K., & Yamamoto, O. (2021). Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis. Yonago acta medica, 64(3), 315-317. https://doi.org/10.33160/yam.2021.08.008
Goto, Hiroyuki, et al. "Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis." Yonago acta medica vol. 64,3 (2021): 315-317. doi: https://doi.org/10.33160/yam.2021.08.008
Goto H, Sugita K, Yamamoto O. Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis. Yonago Acta Med. 2021 Aug 02;64(3):315-317. doi: 10.33160/yam.2021.08.008. eCollection 2021 Aug. PMID: 34429706; PMCID: PMC8380554.
Copy Download .nbib Format: NLM
Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

Drugs - real world outcomes

Tsukada N, Nishikori M, Goto H, Kanamori R, Nishina S, Seto T, Iida S.
PMID: 34455570
Drugs Real World Outcomes. 2021 Aug 29; doi: 10.1007/s40801-021-00276-1. Epub 2021 Aug 29.

BACKGROUND: Plerixafor was approved in Japan in 2016 for peripheral blood stem cell (PBSC) mobilization in autologous stem cell transplantation (A-SCT).OBJECTIVE: Our objective was to evaluate the safety and effectiveness of plerixafor in Japanese patients undergoing A-SCT for various...

Cite
Tsukada N, Nishikori M, Goto H, et al. Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs Real World Outcomes. 2021;doi: 10.1007/s40801-021-00276-1.
Tsukada, N., Nishikori, M., Goto, H., Kanamori, R., Nishina, S., Seto, T., & Iida, S. (2021). Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs - real world outcomes, . https://doi.org/10.1007/s40801-021-00276-1
Tsukada, Nobuhiro, et al. "Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study." Drugs - real world outcomes vol. (2021). doi: https://doi.org/10.1007/s40801-021-00276-1
Tsukada N, Nishikori M, Goto H, Kanamori R, Nishina S, Seto T, Iida S. Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs Real World Outcomes. 2021 Aug 29; doi: 10.1007/s40801-021-00276-1. Epub 2021 Aug 29. PMID: 34455570.
Copy Download .nbib Format: NLM
Showing 3853 to 3858 of 3858 entries